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Purpose: In the prospective KaRen registry of heart failure with preserved
ejection fraction (HFPEF), changes in clinical and biological parameters and
medications were assessed between acute presentation and out-patient follow-
up in stable state.
Methods: The KaRen study included patients presenting with acute heart
failure (HF) according to inclusion criteria: Framingham criteria for HF, left
ventricular ejection fraction > or=45% and brain natriuretic peptide
(BNP)>100 pg/mL or NT-proBNP>300 pg/mL. Once stabilized, 4-8 weeks
after the index presentation, patients returned as out-patients for repeat assess-
ment. Changes in clinical and biological parameters and medications between
inclusion and follow-up were assessed with Students t-test and Chi-square
tests
Results: 577 patients were recruited and 458 returned for the 4-8 weeks
visit. 56% were women. The median [25-75pctl] age was 79 [72-84] years.
Medical history included 78% hypertension, 58% atrial arrhythmia, 26% type
II diabetes and 27% serum creatinin >100 micromol/l. The table provides
inclusion and follow-up data
Conclusions: Patients presenting with HFPEF are elderly and a majority
are women, with a high rate of hypertension and atrial arrhythmias. Blood
pressure is incompletely controlled. At follow-up, blood pressure and NT-
proBNP were reduced, but patients remain symptomatic. Still, efforts are
needed to improve symptoms in HFPEF.
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Aim: Heart failure is known to be a major cause of morbidity and mor-
tality in developed countries. The number of Tunisians suffering from acute
heart failure (AHF) is increasing, but only little is known about the prognosis
and possible risk factors for a fatal outcome in our population. The aim of our
study is to describe patients with AHF with regard to clinical presentation and
mortality at 6 months.
Method and results: We conducted a retrospective study including
234 patients from a Tunisian center hospitalized with AHF.
Our study population’s average age was 65±13.8, 56% were male. Hyper-
tension was noted in 60.3% of the cases, diabetes in 51.7% and 69.7% of the
patients had new-onset heart failure. Ischemic etiology was noted in 48.7% of
cases followed by hypertensive, dilated cardiomyopathy and valvular cardiop-
athy observed respectively in 21.4%, 14.5%, and 11.1% of cases. Left ventric-
ular ejection fraction (LVEF) was reported in 97% of our population. 46.6%
of these had preserved systolic function (LVEF ≥ 45%) and 17.2% had a
LVEF < 30%. At discharge, 41.5% of patients had beta-blockers and 86.8%
either ACE-inhibitors or angiotensin receptor blockers in use.
At six months 25 patients (11.2%) died. We identified several clinical and
biochemical prognostic risk factors in univariate analysis. Independent predic-
tors of 6 months mortality were QRS width ≥130 ms (adjusted HR, 6.15; 95%
CI, 1.25-30.15;p=0.025), hyperglycemia at admission (adjusted HR, 1.32;
95% CI, 1.12-1.56;p=0.001), high serum level of glycated hemoglobin
(adjusted HR, 0.49; 95% CI, 0.39-0.67; p<0.0001), worsening of renal func-
tion during hospitalization (adjusted HR, 13.87; 95% CI, 3.54-54.24;
p<0.0001) and the non-use beta-blockers at discharge (adjusted HR, 0.06;
95% CI, 0.007-0.58; p=0.015). 
Conclusion: We present the characteristics and prognosis of our popula-
tion of AHF patients. Six months mortality is relatively high, and independent
clinical risk factors include wide QRS, hyperglycemia at admission, poorly
controlled diabetes, worsening of renal function during hospitalization and the
non-use beta-blockers at discharge.
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Purpose: To demonstrate the abnormal kinetics of copeptin during stress
in patients with Tako-Tsubo cardiomyopathy (TTC).
Methods: We analyzed prospectively copeptin kinetics before and after
dobutamine echocardiography in 12 TTC compared to 10 controls, matched
for age and gender. The level of the other main stress hormones (adrenaline,
noradrenaline, dopamine, insulin, cortisol) were also collected.
Results: All dobutamine echocardiographies were normal. Before and after
echocardiography, there were no differences in hormones values between TTC
and controls. Surprisingly, after echocardiography in TTC, copeptin decreased,
as did cortisol, noradrenaline, and insulin. In the control group, no variation
was found.
Conclusions: Surprisingly, in TTC after dobutamine echocardiography,
most hormones, including copeptin, decreased.
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Introduction: The prevalence of heart failure and diabetes are both increasing:
25 to 30% of patients with heart failure suffer from diabetes. Diabetics have more
diastolic dysfunction because accumulation collagen in intramyocardial.
The objectives of our study are to compare echocardiographics and
Doppler profiles of diabetics and non diabetics.
Material and methods: We included 1351 patients, diabetics and non dia-
betics, admitted in united of heart failure in Ibn Rochd Center of Cardiology
from May 2006 to October 2010. All patients were evaluated by echocardiog-
raphy and Doppler.
Table (abstract 85) – Inclusion and follow-up data
Variable
Mean (IQR)
YHA I / II / III / IV SBP Creatinine T-proBP ACEI /ARB B-blocker ATICOAG
Inclusion 0.8 / 9.4 / 40 / 49.8% 148 [130-170] 93 [74-128] 2433 [1272-4790] 60% 65% 41%
Follow-up 13 / 62.5 / 22.2 / 2.3 140 [120-150] 95 [75-129] 1409 [514-2641] 68% 67.5% 51.3%
p  <0.0001 0.003 <0.0001   

